Tonix Pharmaceuticals Holding Corp. (TNXP)
NASDAQ: TNXP · Real-Time Price · USD
26.54
+0.23 (0.87%)
At close: Sep 5, 2025, 4:00 PM
26.40
-0.14 (-0.53%)
After-hours: Sep 5, 2025, 7:59 PM EDT
TNXP Market Cap
TNXP has a market cap or net worth of $232.65 million as of September 5, 2025. Its market cap has increased by 2,682.34% in one year.
Market Cap
232.65M
Enterprise Value
107.81M
1-Year Change
2,682.34%
Ranking
Category
Stock Price
$26.54
Market Cap Chart
Since July 16, 2019, TNXP's market cap has increased from $7.29M to $232.65M, an increase of 3,089.71%. That is a compound annual growth rate of 75.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 232.65M | 277.44% |
| Dec 31, 2024 | 61.64M | 160.94% |
| Dec 29, 2023 | 23.62M | 5.35% |
| Dec 30, 2022 | 22.42M | -87.36% |
| Dec 31, 2021 | 177.42M | 37.36% |
| Dec 31, 2020 | 129.17M | 1,226.92% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 16, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 666.94B |
| Johnson & Johnson | 430.51B |
| AbbVie | 376.28B |
| UnitedHealth Group | 281.10B |
| AstraZeneca | 253.90B |
| Novo Nordisk | 249.80B |
| Novartis AG | 249.52B |
| Abbott Laboratories | 231.15B |